43P Development of a production process to generate CD8+ T cell-enriched tumor-nfiltrating lymphocyte (TIL) products with increased cytotoxic potential for the treatment of patients with solid cancers

Autor: Tas, L., van Zon, M., Djuretic, I., Moynihan, K.D., Yeung, Y.A., Mathewson, N., Haanen, J.B.A.G., Jedema, I.
Zdroj: In Immuno-Oncology and Technology December 2022 16 Supplement 1
Databáze: ScienceDirect